MarketPeel
Insider Trading Intelligence
Pricing
…
AR

Alan J. Russell

EWTX
CHIEF SCIENTIFIC OFFICER · EDGEWISE THERAPEUTICS, INC. · CIK 0001853529
FILING MIX · LIFETIME26%/74%
BUYS
23
SELLS
66
TOTAL VALUE
$23.42M
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
154,907
AVG SELL PX
$22.61
TRADE KIND
SHOWING 89 / 89
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
49 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Alan J. Russell, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d49+51.02%+0.39%+0.08%+0.32%+0.68%0.30
14d49+40.82%+0.54%+0.99%-0.45%+0.12%-0.35
30d49+63.27%-1.08%+1.81%-2.90%-2.57%-1.37
60d49+57.14%-3.46%+2.82%-6.29%-7.86%-2.29
90d49+83.67%-15.71%+2.75%-18.46%-25.61%-5.53
180d49+89.80%-35.31%-0.99%-34.32%-48.96%-5.91
1y49(3 pending)+91.30%-30.28%-8.33%-21.95%-30.47%-3.81
2y49(10 pending)+92.31%-52.56%+2.40%-54.96%-65.23%-8.80
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EWTX · 154,907 shares · as of Jul 1, 2026
0364,195728,3901,092,5851,456,78020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 23 buys / 66 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
130,352$0.45$58.7K154,907Jul 1, 2026Jul 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
130,352——0Jul 1, 2026Jul 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
69,648$0.18$12.5K224,555Jul 1, 2026Jul 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
130,352$39.41$5.14M94,203Jul 1, 2026Jul 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
69,648——1,077,717Jul 1, 2026Jul 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
69,648$39.41$2.74M24,555Jul 1, 2026Jul 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
100,000$21.12$2.11M23,400Nov 12, 2025Nov 13, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
100,000$0.18$18.0K123,400Nov 12, 2025Nov 13, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
100,000——1,147,365Nov 12, 2025Nov 13, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
100,000——1,247,365Aug 26, 2025Aug 28, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
100,000$0.18$18.0K123,400Aug 26, 2025Aug 28, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
100,000$14.60$1.46M23,400Aug 26, 2025Aug 28, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,907$13.39$25.5K23,400Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,125——28,125Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
5,781——25,307Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,781——17,344Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
168,750——168,750Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,551$16.45$25.5K18,521May 2, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,209——0May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
5,209——20,072May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
200$0.18$3615,063Mar 7, 2025Mar 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
200$30.02$6.0K14,863Mar 7, 2025Mar 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
200——1,456,580Mar 7, 2025Mar 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,200——1,347,565Feb 6, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,200$30.13$36.2K14,863Feb 6, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
1,200$0.18$21616,063Feb 6, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
8,015$0.18$1.4K22,878Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,015$30.02$240.6K14,863Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
8,015——1,348,765Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
100,000——1,356,780Dec 30, 2024Dec 31, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
100,000$0.18$18.0K114,863Dec 30, 2024Dec 31, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100,000$27.37$2.74M14,863Dec 30, 2024Dec 31, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
74,185$28.25$2.10M13,534Sep 20, 2024Sep 20, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
75,000$0.18$13.5K87,719Sep 20, 2024Sep 20, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
75,000——1,456,780Sep 20, 2024Sep 20, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
815$29.51$24.0K12,719Sep 20, 2024Sep 20, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
138,750——138,750Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,125——23,125Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,576$18.91$29.8K7,238May 2, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,208——5,209May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
5,208——8,814May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
172,585$9.33$1.61M3,606Dec 26, 2023Dec 28, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Aug 17, 2023Aug 18, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,602$8.90$14.3K176,191May 2, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,208——10,417May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
5,208——177,793May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
220,000——220,000Aug 8, 2022Aug 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,625——15,625May 1, 2022May 3, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
147,585——0Nov 30, 2021Dec 1, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
147,585$0.18$26.6K147,585Nov 30, 2021Dec 1, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
25,000$0.45$11.3K172,585Nov 30, 2021Dec 1, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
25,000——130,352Nov 30, 2021Dec 1, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
38$19.61$7450Nov 15, 2021Nov 17, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
441$19.07$8.4K38Nov 15, 2021Nov 17, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
8,562$19.51$167.1K479Nov 12, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
15,595$19.82$309.0K12,722Nov 11, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,681$20.43$75.2K9,041Nov 11, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
580$20.21$11.7K28,317Nov 10, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
11,746$19.70$231.4K28,897Nov 10, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
16,864$19.94$336.3K53,355Nov 9, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
12,712$20.30$258.0K40,643Nov 9, 2021Nov 12, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
9,017$20.16$181.8K70,219Nov 8, 2021Nov 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
6$20.70$12492,272Nov 5, 2021Nov 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
13,036$19.62$255.8K79,236Nov 5, 2021Nov 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
7,392$19.76$146.1K92,278Nov 4, 2021Nov 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
20,822$17.98$374.4K105,032Nov 3, 2021Nov 3, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,119$19.42$21.7K99,670Nov 3, 2021Nov 3, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
4,243$18.84$79.9K100,789Nov 3, 2021Nov 3, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
17,519$17.43$305.4K125,854Nov 2, 2021Nov 3, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
469$18.02$8.5K143,373Nov 1, 2021Nov 3, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
126$18.00$2.3K143,842Oct 15, 2021Oct 18, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,307$18.13$23.7K143,968Oct 15, 2021Oct 18, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,749$18.18$104.5K145,275Oct 14, 2021Oct 18, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,270$18.02$22.9K151,024Oct 11, 2021Oct 13, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,902$18.15$107.1K152,294Oct 8, 2021Oct 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
13,018$18.56$241.6K158,196Oct 7, 2021Oct 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,108$18.03$38.0K171,214Oct 6, 2021Oct 8, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,404$18.26$98.7K173,322Oct 5, 2021Oct 5, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
100$18.00$1.8K178,726Oct 4, 2021Oct 5, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
274$18.00$4.9K178,826Oct 1, 2021Oct 5, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
618$17.47$10.8K179,100Sep 29, 2021Sep 30, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
11,226$16.83$188.9K179,718Sep 29, 2021Sep 30, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
14,610$17.30$252.8K190,944Sep 28, 2021Sep 30, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
17$18.48$314205,554Sep 27, 2021Sep 27, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
11,594$17.98$208.5K205,571Sep 27, 2021Sep 27, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
20,100$18.16$365.0K217,165Sep 24, 2021Sep 27, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
21,763$18.34$399.1K242,337Sep 23, 2021Sep 27, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,072$19.42$98.5K237,265Sep 23, 2021Sep 27, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
120,000——120,000Aug 17, 2021Aug 19, 2021 ↗View →
Other insiders · EWTX
Loading peer insiders…
About this filer
CIK 0001853529
ROLE
Chief Scientific Officer
PRIMARY
EWTX
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001853529DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback